Pittsburgh · Pennsylvania
Knechtel Law Group represents medical device companies before the USPTO nationwide from Carefree, Arizona. Pittsburgh teams working at the edge of robotics, biomaterials, and artificial organs can work with a patent attorney who is also a physician and engineer.
Pittsburgh's device identity was shaped by organ support and regenerative medicine. The McGowan Institute for Regenerative Medicine, a partnership of the University of Pittsburgh and UPMC, traces back to the McGowan Center for Artificial Organ Development founded in 1992 and became a full institute in 2001. Its research is organized around medical devices and artificial organs, tissue engineering and biomaterials, and cellular therapies, with an explicit emphasis on clinical translation.
The second pillar is robotics. Carnegie Mellon University's Robotics Institute has groups devoted to surgical and healthcare robotics, including work on handheld instruments that counteract tremor during microsurgery. Snake-like robot research by CMU professor Howie Choset led to the Flex Robotic System from Medrobotics, which received FDA clearance in 2015 for transoral procedures. The combination of engineering depth at CMU and clinical scale at UPMC gives the city an unusual supply of mechatronic and software-driven device concepts.
Commercialization pathways are closely tied to those institutions. UPMC Enterprises serves as the health system's innovation, commercialization, and venture arm. AlphaLab Health, developed by Innovation Works with Allegheny Health Network, runs an accelerator for early-stage companies in areas that include medical devices and diagnostics. The region also carries a recent reminder of how closely regulators examine device manufacturing: in April 2024 the federal court for the Western District of Pennsylvania entered a consent decree with Philips Respironics, following the 2021 recall of certain sleep and respiratory devices, restricting production at its Pennsylvania facilities until specified requirements are met.
For patent planning, several points stand out. Robotic systems combine mechanical design, control software, and user interface, and a durable portfolio claims each layer rather than relying on one broad system claim. Inventions from academic and health-system collaborations may involve more than one institution, so ownership and prosecution control should be agreed in writing. Biomaterial and artificial-organ technologies often turn on manufacturing methods, which can be claimed directly or kept as trade secrets. And because the Western District of Pennsylvania has its own Local Patent Rules, with the current version effective December 2015, enforcement planning there follows a defined disclosure schedule.
Patent Strategy Considerations
A robotic platform can be protected at several levels: the mechanism and kinematics, the control methods, the instrument interfaces, and the surgical workflow. Separate claim sets, supported by detailed drawings and algorithm descriptions at filing, make it harder for a competitor to avoid the portfolio by changing a single element.
When a device emerges from a university lab and a health system's clinical teams together, each institution may hold rights. An inter-institutional agreement that designates who files, who pays, and who can license should be in place before the first application, so investors see one clear path to exclusive rights.
Design controls and quality records that regulators expect can also support conception dates, inventorship, and enablement when prepared with care. Coordinating invention disclosures with design history documentation reduces the risk of inconsistent descriptions between the patent file and the regulatory file.
How Engagements Work
Knechtel Law Group is based in Carefree, Arizona. Patent prosecution and counseling before the U.S. Patent and Trademark Office is federal practice, and engagements with Pittsburgh-area companies are handled directly by senior counsel by video and in person as needed. Matters that turn on state law may call for local counsel.
Request a Confidential ConsultationCommon Questions
Not for patent prosecution. USPTO practice is federal, and a registered patent attorney may represent applicants from any state. State-law matters, such as employment or contract disputes under Pennsylvania law, and litigation in Pennsylvania courts may require counsel admitted there, and we can coordinate with local counsel as needed.
It depends on whether the technique is visible in the product or discoverable by competitors. Features that can be observed or reverse engineered are usually better candidates for patents, while internal methods that stay hidden may be protected as trade secrets under Pennsylvania's Uniform Trade Secrets Act, if reasonable secrecy measures are maintained.
Yes. The court has Local Patent Rules, with the current version effective December 5, 2015, governing disclosures, contentions, and claim construction. Drafting claims and maintaining records with that structure in mind helps a company evaluate enforcement options later.
Discuss Your Portfolio
Schedule a confidential consultation to discuss your technology, your existing portfolio, and your plans.
Request a Confidential Consultation